About ASCP. Includes contact information. Membership resources and application Meetings, conventions, and many more educational opportunities The Consultant Pharmacist, ASCP Update, Clinical Consult, Business Quarterly, TCP Supplements, and the ASCP Product Catalog Extensive resources for the new pharmacy practicioner News and press releases from ASCP Extensive resources to help you advance your practice Up-to-date information on legislative and regulative activities affecting your practice. Includes the ASCP Advocacy Center. Discussion forums and career resources What's happening in the next year American Society of Consultant Pharmacists Research and Education Foundation
ascp.rxschool.com

CE Home | Help | Login | Register   

 The “Wearing-Off” Phenomenon in Parkinson’s Disease: Current Strategies for Optimizing Dopaminergic Therapy in Long-Term Care

If you attended the live event and would like to receive credit please log in.
Type: Seminar
Date(s): 05/16/05
Times: 7:00 AM - 9:15 AM ET
6:00 AM - 8:15 AM CT
5:00 AM - 7:15 AM MT
4:00 AM - 6:15 AM PT
Facility: TBA
  Orlando , FL
Fee: No Charge!
 Live CE Information

This activity will provide consultant pharmacists with an overview of current treatment options available for the management of Parkinson’s disease, and effective strategies for preventing and/or managing the “wearing-off” phenomenon commonly associated with levodopa, while emphasizing critical aspects of their role as members of an interdisciplinary team in optimizing patient outcomes.

Supported by an educational grant from Novartis Pharmaceuticals Corporation

Learning Objectives:

1. Discuss the available pharmacologic treatments for Parkinson's disease, including levodopa, dopamine agonists, DDC and COMT inhibitors, and amantadine

2. Demonstrate a comprehensive understanding of the "wearing-off" phenomenon associated with levodopa-based treatment of patients with Parkinson's disease

3. Identify safe and effective treatment strategies for circumventing the "wearing-off” phenomenon of levodopa therapy, taking into account comorbidities, drug interactions, and side-effect profiles

4. Describe the consultant pharmacist’s role, in collaboration with other members of the interdisciplinary healthcare team, in improving outcomes in patients with Parkinson’s disease

 

Instructors & Credentials:

Jack J. Chen, PharmD, BCPS, CGP, FASCP
Adjunct Assistant Professor of Neurology
Movement Disorders Clinic
Loma Linda University
Loma Linda, CA
Assistant Professor (Neurology)
Department of Pharmacy Practice
Western University of Health Sciences
Pomona, CA

Stuart H. Isaacson, MD
Director
Parkinson’s Disease and Movement Disorders Center
Boca Raton, FL
Assistant Professor of Neurology (Vol)
University of Miami School of Medicine
Miami, FL

Instructor Disclosure:     

Jack J. Chen, PharmD, BCPS, CGP, FASCP
Honoraria: Boehringer-Ingelheim, GlaxoSmithKline, Teva Neuroscience, Mylan Bertek
Consultancies: Teva Neuroscience

Stuart H. Isaacson, MD
Honoraria: Bertek, Boehringer-Ingelheim, GlaxoSmithKline, Novartis
Consultancies: Bertek, Novartis, GlaxoSmithKline, Teva
Research Funding: Bertek, Teva, Novartis, GlaxoSmithKline, Boehringer-Ingelheim
Promotional Speakers Bureau: Bertek, Boehringer-Ingelheim, GlaxoSmithKline, Novartis
 Courses Offered
 The “Wearing-Off” Phenomenon in Parkinson’s Disease: Current Strategies for Optimizing Dopaminergic Therapy in Long-Term Care
Details:
 

ACPE Accreditation
Credit Hours: 2.25 Expiration Date: ACPE UPN: 203-799-05-002-L01    

ASCP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To receive CE credit, participants must complete an online evaluation form for each session attended. After completing the evaluation, you can view, print and track your CE statements of credit online. There is no fee to participate in this activity.


The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.



Powered By RxSchool

© Copyright 2010 RxSchool